Grant of Options
30 September 2026
Aminex plc
("Aminex" or "the Company")
Grant of Options
Aminex announces that, following a recommendation of the Remuneration Committee, the Board has approved the grant of 70 million compensation share options (the "Options") under the Aminex PLC Restricted Share Plan (the "Plan").
The Options are the first share options granted by the Company in over three years and are being awarded as compensation in lieu of increases in salaries and directors' fees and in lieu of performance bonuses.
The Options have been granted to:
· Charles Santos, Executive Chairman - 30 million options
· Tom Mackay, Senior Independent Director - 10 million options
· Staff - 30 million options
The Options are granted pursuant to the terms of the Plan and have an exercise price of 2.00 pence per share. The Options will vest on 1 January 2027 and have a five-year life.
The awards reflect the Company's continued disciplined approach to cash preservation and remuneration while aligning the interests of directors and staff with those of shareholders.
The Board has also approved the extension of existing options granted to Tom Mackay, Senior Independent Director, and certain members of staff that were due to expire on 11 November 2026 for one year (the "2019 Options"). The grant of the 2019 Options was made as an incentive to participants to remain with the Company through to delivery of the Ntorya gas development, that has now been delayed to the end of 2026 and into 2027. The Board also noted that the options granted to certain directors and members of staff in January 2022 are due to expire in January 2027 and cannot be extended under the terms of the Plan.
Director/PDMR Shareholding
The notification below is made in accordance with the Article 19 of the Market Abuse Regulation (EU) 596/2014, as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended.
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Charles Santos
2
Reason for the notification
a)
Position/status
Director
b)
Initial Notification Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Aminex PLC
b)
LEI
635400CSEBJAYPUUFC95
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument,
type of
instrument
Identification code
Ordinary Shares of €0.001 each
IE0003073255
b)
Nature of the transaction
Grant of Options over Ordinary Shares
c)
Price(s) and volume(s)
Options over 30,000,000 Ordinary Shares at an exercise price of 2.00 pence each
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
28 September 2026
f)
Place of the transaction
London Stock Exchange
g)
Additional Information
Options will vest on 1 January 2027
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Thomas Mackay
2
Reason for the notification
a)
Position/status
Director
b)
Initial Notification Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Aminex PLC
b)
LEI
635400CSEBJAYPUUFC95
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument,
type of
instrument
Identification code
Ordinary Shares of €0.001 each
IE0003073255
b)
Nature of the transaction
Grant of Options over Ordinary Shares
c)
Price(s) and volume(s)
Options over 10,000,000 Ordinary Shares at an exercise price of 2.00 pence each
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
28 September 2026
f)
Place of the transaction
London Stock Exchange
g)
Additional Information
Options will vest on 1 January 2027
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Thomas Mackay
2
Reason for the notification
a)
Position/status
Director
b)
Initial Notification Amendment
Amendment
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Aminex PLC
b)
LEI
635400CSEBJAYPUUFC95
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument,
type of
instrument
Identification code
Ordinary Shares of €0.001 each
IE0003073255
b)
Nature of the transaction
Extension of Grant of Options over Ordinary Shares to 11 November 2027
c)
Price(s) and volume(s)
Options over 20,000,000 Ordinary Shares at an exercise price of 1.40 pence each granted on 11 November 2019
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
28 September 2026
f)
Place of the transaction
London Stock Exchange
g)
Additional Information
Options originally due to expire on 11 November 2026 extended to 11 November 2027
For further information:
Aminex PLC
+44 203 355 9909
Charles Santos, Executive Chairman
Knights Media & Public Relations
aminex@knightsmpr.com
Sabina Zawadzki
Davy
+353 1 679 6363
Brian Garrahy
Shard Capital
+44 20 7186 9952
Damon Heath
Axis Capital Markets
+44 203 026 0320
Richard Hutchison
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHDGGDCLSDDGLC
